Demcizumab
Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody and a potent Notch pathway inhibitor, demonstrating efficacy in various cancer models both as a monotherapy and in conjunction with chemotherapy agents.
Product Specifications
CAS Number
1243262-17-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
145.65 (kDa)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Gamma-secretase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog